e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Insight into mechanisms of respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations?
K. Rohmann, E. Chen, J. Rupp, T. Goldmann, D. Droemann, K. Dalhoff (Luebeck, Borstel, Germany; Hangzhou, China)
Source:
Annual Congress 2011 - Insight into mechanisms of respiratory infections
Session:
Insight into mechanisms of respiratory infections
Session type:
Poster Discussion
Number:
3504
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Rohmann, E. Chen, J. Rupp, T. Goldmann, D. Droemann, K. Dalhoff (Luebeck, Borstel, Germany; Hangzhou, China). Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations?. Eur Respir J 2011; 38: Suppl. 55, 3504
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017
The role of viral and bacterial infections in asthma severity
Source: Annual Congress 2005 - PG3 - Asthma: natural history, risk factors and overall management
Year: 2005
Interplay between bacterial infections, hypoxia and the development of chronic lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Human rhinovirus 16 infection of human macrophages disrupts Arpin expression impairing macrophage internalization: a potential link to exacerbation in chronic obstructive pulmonary disease?
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Antiapoptotic and proinflammatory function of toll-like receptor 2 in acute
C. pneumoniae
infection of COPD lung tissue
Source: Eur Respir J 2006; 28: Suppl. 50, 575s
Year: 2006
The role of viral and bacterial infections on the development and exacerbations of asthma
Source: Eur Respir Mon 2012; 56: 115-127
Year: 2012
Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease
Source: Eur Respir J 2007; 30: 736-742
Year: 2007
Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
The role of viruses including metapneumovirus in COPD exacerbation
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005
The role bacterial and viral infection in COPD exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 33s
Year: 2006
Chlamydia pneumoniae
persists in COPD lung tissue: predominant role of toll-like receptor 2 versus 4 in
chlamydia pneumoniae
-induced activation of pulmonary immune cells
Source: Eur Respir J 2004; 24: Suppl. 48, 240s
Year: 2004
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Source: Eur Respir J 2008; 32: 1068-1081
Year: 2008
Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
YS1: Immunomodulatory function of chemerin and its receptor ChemR23 in the physiopathology of viral pneumonia and acute lung injury
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011
Pathomechanisms mediating bacterial co-infection following respiratory viral disease
Source: Lung Science Conference 2015
Year: 2015
Role of Toll-like receptor 4 in acute pulmonary inflammation induced by bacterial components in mice
Source: Eur Respir J 2005; 26: Suppl. 49, 730s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept